Paper36346113
PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?
Parker VL and 14 others. Int J Cancer, 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia? Papers, record 36346113. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36346113
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gestational Trophoblastic Disease | Major topic |
| Pregnancy | |
| Female | |
| Humans | |
| Retrospective Studies | |
| Models, Statistical |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Department of Health | United Kingdom | PubMed | ||
| Cancer Research UK | United Kingdom | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36346113 | PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia? | Int J Cancer | 2023 | https://conductscience.org/library/papers/36346113 | PubMed |
| 2 | 18299618 | Ockham's razor: sharpen or re-sheathe? | J R Soc Med | 2008 | https://conductscience.org/library/papers/18299618 | PubMed |
| 3 | 20160727 | The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1). | Br J Cancer | 2010 | https://conductscience.org/library/papers/20160727 | PubMed |
| 4 | 29653688 | Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients. | Gynecol Oncol | 2018 | https://conductscience.org/library/papers/29653688 | PubMed |
| 5 | 31592444 | A simple, step-by-step guide to interpreting decision curve analysis. | Diagn Progn Res | 2019 | https://conductscience.org/library/papers/31592444 | PubMed |
| 6 | 31375268 | When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients. | Gynecol Oncol | 2019 | https://conductscience.org/library/papers/31375268 | PubMed |
| 7 | 26569059 | Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group-174 Phase III Trial. | Int J Gynecol Cancer | 2016 | https://conductscience.org/library/papers/26569059 | PubMed |
| 8 | 22374461 | Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia. | Br J Cancer | 2012 | https://conductscience.org/library/papers/22374461 | PubMed |
| 9 | 28381180 | Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences. | Tumour Biol | 2017 | https://conductscience.org/library/papers/28381180 | PubMed |
| 10 | 23818445 | Identification of complete hydatidiform mole pregnancy-associated microRNAs in plasma. | Clin Chem | 2013 | https://conductscience.org/library/papers/23818445 | PubMed |
| 11 | 25016558 | Clinical applications of analysis of plasma circulating complete hydatidiform mole pregnancy-associated miRNAs in gestational trophoblastic neoplasia: a preliminary investigation. | Placenta | 2014 | https://conductscience.org/library/papers/25016558 | PubMed |
| 12 | 27281496 | First-line chemotherapy in low-risk gestational trophoblastic neoplasia. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27281496 | PubMed |
| 13 | 7564793 | Comparing methods of measurement: why plotting difference against standard method is misleading. | Lancet | 1995 | https://conductscience.org/library/papers/7564793 | PubMed |
| 14 | 26760424 | Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/26760424 | PubMed |
| 15 | 11919242 | Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/11919242 | PubMed |
| 16 | 23999759 | Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2013 | https://conductscience.org/library/papers/23999759 | PubMed |
| 17 | 19132141 | Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers. | Am Stat | 2008 | https://conductscience.org/library/papers/19132141 | PubMed |
| 18 | 33210289 | M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia. | Int J Cancer | 2021 | https://conductscience.org/library/papers/33210289 | PubMed |
| 19 | 30889489 | miR-196b inhibits cell migration and invasion through targeting MAP3K1 in hydatidiform mole. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30889489 | PubMed |
| 20 | 28482228 | Classification systems in Gestational trophoblastic neoplasia - Sentiment or evidenced based? | Cancer Treat Rev | 2017 | https://conductscience.org/library/papers/28482228 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42473063 | FIGO staging for gestational trophoblastic neoplasia: 2026. | Int J Gynaecol Obstet | 2026 | https://conductscience.org/library/papers/42473063 | PubMed |
| 41306756 | Correlation Between Serum and Urine β-hCG in Gestational Trophoblastic Neoplasia: A Step Toward Non-Invasive Disease Monitoring. | Int J Womens Health | 2025 | https://conductscience.org/library/papers/41306756 | PubMed |
| 39583749 | Prognosticating gestational trophoblastic neoplasia: from FIGO 2000 to future models. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/39583749 | PubMed |
| 38590416 | Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0-4). | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/38590416 | PubMed |
| 37827125 | From National to International Collaboration in Gestational Trophoblastic Disease: Hurdles and Possibilities. | Gynecol Obstet Invest | 2024 | https://conductscience.org/library/papers/37827125 | PubMed |
| 36346113 | PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia? | Int J Cancer | 2023 | https://conductscience.org/library/papers/36346113 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CGB5 | 93659 | PubTator's text mining | https://conductscience.org/library/genes/93659 | NCBI Gene |
| GDF2 | 2658 | PubTator's text mining | https://conductscience.org/library/genes/2658 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36346113
GET https://conductscience.org/api/papers/v1/36346113/references?page=2